Research output per year
Research output per year
Fingerprint
Dive into the research topics where Saranya Chumsri is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 9 Similar Profiles
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research output
-
Carryover effects of aromatase inhibitors in prevention
Chumsri, S. & Thompson, E. A., Jan 11 2020, In: The Lancet. 395, 10218, p. 91-92 2 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Durable complete response with immune checkpoint inhibitor in breast cancer with high tumor mutational burden and APOBEC signature
Chumsri, S., Sokol, E. S., Soyano-Muller, A. E., Parrondo, R. D., Reynolds, G. A., Nassar, A. & Thompson, E. A., May 2020, In: JNCCN Journal of the National Comprehensive Cancer Network. 18, 5, p. 517-521 5 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Long-term cardiac outcomes of patients with HER2-positive breast cancer treated in the adjuvant lapatinib and/or trastuzumab Treatment Optimization Trial
Eiger, D., Pondé, N. F., Agbor-Tarh, D., Moreno-Aspitia, A., Piccart, M., Hilbers, F. S., Werner, O., Chumsri, S., Dueck, A., Kroep, J. R., Gomez, H., Láng, I., Rodeheffer, R. J., Ewer, M. S., Suter, T. & de Azambuja, E., May 12 2020, In: British journal of cancer. 122, 10, p. 1453-1460 8 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Predictive Biomarkers for Adjuvant Capecitabine Benefit in Early-Stage Triple-Negative Breast Cancer in the FinXX Clinical Trial
Asleh, K., Brauer, H. A., Sullivan, A., Lauttia, S., Lindman, H., Nielsen, T. O., Joensuu, H., Thompson, E. A. & Chumsri, S., Jun 1 2020, In: Clinical Cancer Research. 26, 11, p. 2603-2614 12 p.Research output: Contribution to journal › Article › peer-review
3 Scopus citations -
Prognostic role of distant disease-free interval from completion of adjuvant trastuzumab in HER2-positive early breast cancer: Analysis from the ALTTO (BIG 2-06) trial
Lambertini, M., Agbor-Tarh, D., Metzger-Filho, O., Ponde, N. F., Poggio, F., Hilbers, F. S., Korde, L. A., Chumsri, S., Werner, O., Del Mastro, L., Caparica, R., Moebus, V., Moreno-Aspitia, A., Piccart, M. J. & De Azambuja, E., Nov 3 2020, In: ESMO Open. 5, 6, e000979.Research output: Contribution to journal › Article › peer-review
Open Access